WuXi Biologics Cayman Inc., one of China’s leading drug contract research and manufacturing companies, said its chief executive officer has not worked for any military-affiliated institution. The stock was hammered in Hong Kong on Friday following the news that proposed US legislation would ban the company from American government contracts. Sangmi Cha reports on Bloomberg Television. (Source: Bloomberg)
WuXi Bio Denies Military Ties After Shares Slumped on US Bill
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...